0001553878-13-000001.txt : 20130212 0001553878-13-000001.hdr.sgml : 20130212 20130212174456 ACCESSION NUMBER: 0001553878-13-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130208 FILED AS OF DATE: 20130212 DATE AS OF CHANGE: 20130212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reid Laurence CENTRAL INDEX KEY: 0001492749 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50743 FILM NUMBER: 13598582 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-02-08 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001492749 Reid Laurence 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, Chief Business Officer Common Stock 2013-02-08 4 M 0 5000 7.1 A 16681 D Common Stock 2013-02-08 4 S 0 5000 25 D 11681 D Common Stock 1507 I By Managed Account Stock Option (Right to Buy) 7.1 2013-02-08 4 M 0 5000 0 D 2021-11-30 Common Stock 5000 35000 D The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2012. The reporting person owns 1,507 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. /s/ Michael P. Mason, as Attorney-in-Fact for Laurence Reid 2013-02-12